This ISN’T your regular biotech stock! We’re seeing strong bullish signals

Sponsored by MYMD, See Disclosure Below Hey trader! Biotech stocks have been on fire lately! The IBB (iShares Biotechnology ETF) is recovering from a low of $106 and approaching $160. XBI (S&P Biotech Index) turned up off the low $60 zone to trade near $90, after a fall from $170s last year. When you add that to massive moves like; APDN rocketing over 480% in the last 5 days…GOVX rallying over 500% in a little over a week…and NVIV trading over 109% higher in the pre-market this morning… It’s clear biotechs are squarely in the sights of traders again. But… One stock we’re particularly excited about is MYMD! You’ll see why. If you didn’t know… They’re a pharmaceutical company that develop drug products to combat aging, age-related, and autoimmune diseases. After consolidating from last month’s spike, MYMD is recovering and now trading near $4.30 (almost 10% higher in the last 5 days). The move came after news was released regarding a drug they have in development aimed at delaying some of the effects of aging. When trading penny stocks like this one, some key things we look for are indicators that hint at trend continuation. Let’s quickly go over two of those; First, the parabolic SAR — an indicator traders rely on to understand trend direction and potential reversals. It shows as a series of dots either above or below the stock’s price…depending on the direction the price is moving. Dots placed above the price indicate it is trending downward. But if the dots appear below the price…that’s a solid bullish signal. After popping up above MYMD in the last few weeks… SAR dots are catching up to the price and just went under again today — which shows a bullish reversal is imminent…just like at the start of July. Then again, SAR buy signals are a lot more convincing when the stock is trading above a long-term moving average. When we overlay a 100-day moving average on the chart… It’s clear that MYMD is trading way above that $3.35 level, which confirms for us the bullish signal. All this sounds good, but for skilled traders, it makes sense to use different indicators to confirm a signal…rather than relying on just one. A good one to pair with SAR is the Stochastic Oscillator (lower indicator on the chart below). It helps traders figure out if a stock is overbought (readings over 80) or if its oversold (readings under 20). There are two things to note here; If there’s a divergence…when a stock’s price reaches a new lowest low or highest high, while the stochastic oscillator forms a higher low or lower high… That’s usually the first indication of a potential reversal. Divergence alone cannot confirm a reversal…so it’s important to look at the oscillator level. If it breaks above 50 — which MYMD did two days ago — it’s more likely a reversal from a downward to upward trend will follow. MYMD also crossed oversold territory about a week ago. And based on past data, when this happens, it can indicate an increase in price. We’re watching the stock closely and think you might want to as well. We believe there’s a pretty good chance we’ll see a breakout past $5, especially as we approach the August 15 earnings date. 62 Calef Hwy #233 Lee, New Hampshire 03861 United States Questions or concerns about our products? Email Support@ragingbull.com  © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions  Disclaimer FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, neither Sherwood Ventures, LLC (“Sherwood”) nor Ragingbull.com, LLC (“Raging Bull”) can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither Sherwood nor Raging Bull, or any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at [. TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. ISSUER-PAID ADVERTISEMENT. MyMD, Inc. (“MYMD” or the “Company”) has paid or will pay Sherwood $20,000 USD per month for three months (the “Initial Term”) in cash, shares of restricted common stock with a value of $150,000, and warrants valued at issuance of $75,000 for marketing services including communicating to the public about the Company through Sherwood’s affiliate, Raging Bull, among others. This advertisement is part of those issuer-paid marketing services. The contract with MYMD automatically renews for successive one-month periods following the Initial Term (the “Renewal Term”) unless it is terminated by written notice of either party prior to the end of the previous term. During the Renewal Term, MYMD has agreed to pay Sherwood a monthly fee of $30,000 in cash, shares of restricted stock with a value of $50,000 and warrants valued at $25,000. As a result of this advertisement and other marketing efforts, Sherwood and/or Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, Sherwood and Raging Bull, and any of their respective officers, principals, or affiliates (as defined in the Securities Act of 1933, as amended, and Rule 501(b) promulgated thereunder) hold the securities of MYMD and, as permitted by law, may sell those shares during the course of this marketing arrangement or afterwards. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of MYMD, increased trading volume, and possibly an increased share price of the MYMD’s securities, which may or may not be temporary and decrease once the marketing arrangement has ended. [Manage your email subscriptions.](